Achieve Life Sciences (ACHV) Misses Q2 EPS by 27c

Achieve Life Sciences (NASDAQ: ACHV) reported Q2 EPS of ($1.08), $0.27 worse than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Jefferies bullish on Deckers Outdoor, sees HOKA growth slowdown as oversold
• Knight Transportation (KNX) PT Raised to $85 at Stifel Ahead of Q2 Earnings